v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Additional paid in capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022   142,268      
Beginning Balance at Dec. 31, 2022 $ 405,435 $ 1,185,309 $ 85,489 $ (1,061) $ (864,302)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units (in shares)   1,127      
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units 3,024 $ 11,141 (8,117)    
Issuance of common shares in conjunction with ESPP program (in shares)   210      
Issuance of common shares in conjunction with ESPP program 906 $ 2,110 (1,204)    
Share-based compensation 33,543   33,543    
Unrealized gain on available-for-sale securities, net 114     114  
Net income (loss) (51,145)       (51,145)
Ending Balance (in shares) at Sep. 30, 2023   143,605      
Ending Balance at Sep. 30, 2023 391,877 $ 1,198,560 109,711 (947) (915,447)
Beginning Balance (in shares) at Jun. 30, 2023   143,369      
Beginning Balance at Jun. 30, 2023 392,292 $ 1,196,480 98,832 (1,020) (902,000)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units (in shares)   236      
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units 1,151 $ 2,080 (929)    
Share-based compensation 11,808   11,808    
Unrealized gain on available-for-sale securities, net 73     73  
Net income (loss) (13,447)       (13,447)
Ending Balance (in shares) at Sep. 30, 2023   143,605      
Ending Balance at Sep. 30, 2023 $ 391,877 $ 1,198,560 109,711 (947) (915,447)
Beginning Balance (in shares) at Dec. 31, 2023 143,833 143,833      
Beginning Balance at Dec. 31, 2023 $ 377,954 $ 1,200,218 120,788 (730) (942,322)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units (in shares) 125 2,548      
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units $ 646 $ 23,966 (23,320)    
Shares repurchased and cancelled, inclusive of transaction costs (in shares)   (3,424)      
Shares repurchased and cancelled, inclusive of transaction costs (18,619) $ (18,619)      
Issuance of common shares in conjunction with ESPP program (in shares)   152      
Issuance of common shares in conjunction with ESPP program 703 $ 1,048 (345)    
Share-based compensation 22,650   22,650    
Unrealized gain on available-for-sale securities, net 345     345  
Net income (loss) $ 4,323       4,323
Ending Balance (in shares) at Sep. 30, 2024 143,109 143,109      
Ending Balance at Sep. 30, 2024 $ 388,002 $ 1,206,613 119,773 (385) (937,999)
Beginning Balance (in shares) at Jun. 30, 2024   142,984      
Beginning Balance at Jun. 30, 2024 364,616 $ 1,205,554 112,270 (859) (952,349)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units (in shares)   125      
Shares issued on exercise of stock options and vesting of performance awards and restricted stock units 235 $ 1,059 (824)    
Share-based compensation 8,327   8,327    
Unrealized gain on available-for-sale securities, net 474     474  
Net income (loss) $ 14,350       14,350
Ending Balance (in shares) at Sep. 30, 2024 143,109 143,109      
Ending Balance at Sep. 30, 2024 $ 388,002 $ 1,206,613 $ 119,773 $ (385) $ (937,999)